This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The General Hosptial Corporation. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations of Okay Saydam
Introduction
Okay Saydam is an accomplished inventor based in Vienna, Austria. He has made significant contributions to the field of molecular biology, particularly in the area of RNA targeting and microvesicle technology. His innovative work has the potential to impact therapeutic applications significantly.
Latest Patents
Okay Saydam holds a patent for "Targeting RNAs to microvesicles." This patent discloses an isolated nucleic acid molecule that comprises a specific nucleic acid sequence, operably linked to a second, heterologous nucleic acid sequence. The isolated nucleic acid molecule can be in the form of DNA or RNA, including mRNA, shRNA, or ncRNA. The patent also details a microvesicle that contains the nucleic acid molecule and methods for producing a microvesicle preparation enriched for a specific RNA sequence. These methods involve transfecting cells with the nucleic acid sequence and isolating the generated microvesicles. Additionally, the patent outlines methods for delivering therapeutic RNA to a subject.
Career Highlights
Okay Saydam is associated with The General Hospital Corporation, where he continues to advance his research and innovations. His work is characterized by a commitment to developing novel solutions in the field of RNA therapeutics.
Collaborations
Some of his notable coworkers include Mehmet Fatih Bolukbasi and Arda Mizrak. Their collaborative efforts contribute to the ongoing research and development in their respective fields.
Conclusion
Okay Saydam's innovative contributions to RNA targeting and microvesicle technology highlight his role as a leading inventor in molecular biology. His patent and ongoing research have the potential to pave the way for new therapeutic approaches.